capaDATA
  • PERFORMANCE
    • Younger saver, 30 years to retirement – 5-year annualised returns
    • Younger saver, 30 years to retirement – 3-year annualised returns
    • Younger saver, 30 years to retirement – 1-year annualised returns
    • Older saver, 5 years to retirement – 5-year annualised returns
    • Older saver, 5 years to retirement – 3-year annualised returns
    • Older saver, 5 years to retirement – 1-year annualised returns
  • RISK/RETURN
    • Risk/Return – Younger saver, 30 years from retirement, 5-year annualised
    • Risk/Return – Younger saver, 30 years from retirement, 3-year annualised
    • Risk/Return – Younger saver, 30 years from retirement, 1-year annualised
    • Risk/Return – Older saver, 5 years from retirement, 5-year annualised
    • Risk/Return – Older saver, 5 years from retirement, 3-year annualised
    • Risk/Return – Older saver, 5 years from retirement, 1-year annualised
  • PROVIDERS
    • Aegon Master Trust
    • Aon Master Trust
    • Atlas Master Trust
    • Aviva Master Trust
    • The Bluesky Pension Scheme
    • Ensign Retirement Plan
    • Fidelity Master Trust
    • Legal & General Investment Management – WorkSave Pension Mastertrust
    • LifeSight (Willis Towers Watson)
    • Mercer Master Trust
    • National Employment Savings Trust (NEST)
    • Now: Pensions
    • The People’s Pension
    • Salvus Master Trust
    • Scottish Widows Master Trust
    • Smart Pension
    • Standard Life DC Master Trust
    • SuperTrust UK Master Trust
    • TPT Retirement Solutions
    • Welplan Pensions
  • Research
    • ADVISERS
      • Pension provider selection factors
      • Switching
      • Diversification
      • Illiquids
      • ESG
      • Green
      • Digital
      • Consolidation
    • PROVIDERS
      • Master Trusts by number of members
      • Master Trust defaults by assets and number of employers
      • Member charges
      • Employer charges
      • Master trust investment advisers
      • Equity exposure
      • Derisking
      • Asset managers used
  • NEWS
  • MORE
    • About
    • Advertise
    • Contact us
    • Privacy policy
    • Content syndication
    • Terms & Conditions
CAPA
No Result
View All Result

Former Bupa commercial director leaves healthcare industry

28 November 2022
Aviva Investors DC head departs
Share on TwitterShare on FacebookShare on LinkedIn

Former Bupa commercial director Patrick Watt has taken a role at Nord Anglia Education as its chief admissions officer, leaving the healthcare industry altogether.

Watt left Bupa in August following a restructuring of the company. According to Bupa, its long-term strategy aims to promote growth in our IPMI portfolio, offer customers services that are unmatched in the market, and collaborate with our distribution partners. Bupa says that it is establishing more distinct lines of authority across all of its global areas in order to bring decision-making closer to its customers in order to carry out its long-term growth strategy.

The company says that in order to have full accountability for performance, sales, and distribution for each region, it has established three regional business units, each of which is headed by a general manager.

Conor Heery and Dean Pollard will both remain in their roles as general managers of Europe and the Middle East and Asia, respectively. Subject to regulatory approval, Nichola Thomson will join Bupa Global in January 2023 as general manager for the UK and Africa.

In a Linkedin post. Watt said: “Together with Richard Seymour (Chief Marketing Officer) we will be responsible for growing the revenue across our family of 82 schools. It felt like a big decision to move to a new business in a different sector after over 20 years in health and financial services, but I am so pleased I made the change.

“Nord Anglia is an incredible business that provides the very best educational experience for their 75k young people and children. I am so impressed with our 14k teaching colleagues for their relentless focus on educating and equipping our students with the skills to succeed in a fast-changing world. A huge thank you to Andrew Fitzmaurice, our executive team, investors and principals for a warm welcome.”

The post Former Bupa commercial director leaves healthcare industry appeared first on Corporate Adviser.

TweetShareShare
Previous Post

Aviva launches new D&I healthcare benefits

Next Post

Rise in number of pensions accessed without advice

Category

  • By Provider
  • News
  • Not for search
  • Provider page archive
  • Uncategorized
  • video
CAPA data

© 2019-2024 Definite Article Media Limited. Design by 71 Media Limited.

  • About
  • Advertise
  • Contact us
  • Privacy policy
  • Syndication

Follow us

No Result
View All Result
  • About
  • Advertise
  • Contact us
  • Privacy policy
  • Syndication

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.AcceptReject Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT
No Result
View All Result
  • About
  • Advertise
  • Contact us
  • Privacy policy
  • Syndication